-
1
-
-
0027276027
-
Metformin-associated lactic acidosis in Sweden 1977-1991
-
Metformin-associated lactic acidosis in Sweden 1977-1991. Wiholm BE, Myrhed M, Eur J Clin Pharmacol 1993 44 589 591 10.1007/BF02440866 8405019 (Pubitemid 23197849)
-
(1993)
European Journal of Clinical Pharmacology
, vol.44
, Issue.6
, pp. 589-591
-
-
Wiholm, B.-E.1
Myrhed, M.2
-
2
-
-
60449089649
-
Medical management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
-
10.2337/dc08-9025 18945920
-
Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Nathan DM, Buse JB, Davidson MB Ferrannini E, Holman RR, Sherwin R, Zinman B, American Diabetes Association, Diabetes Care 2009 32 1 193 203 10.2337/dc08-9025 18945920
-
(2009)
Diabetes Care
, vol.32
, Issue.1
, pp. 193-203
-
-
Nathan, D.M.1
Buse, J.B.2
Davidson Mb Ferrannini, E.3
Holman, R.R.4
Sherwin, R.5
Zinman, B.6
-
3
-
-
75549091263
-
Statement by an American Association of Clinical Endocrinologists/ American College of Endocrinology consensus panel on type 2 diabetes mellitus: An algorithm for glycemic control
-
10.4158/EP.15.6.540 19858063
-
Statement by an American Association of Clinical Endocrinologists/ American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control. Rodbard HW, Jellinger PS, Davidson JA, Endocr Pract 2009 15 6 540 559 10.4158/EP.15.6.540 19858063
-
(2009)
Endocr Pract
, vol.15
, Issue.6
, pp. 540-559
-
-
Rodbard, H.W.1
Jellinger, P.S.2
Davidson, J.A.3
-
4
-
-
77950868733
-
Risk of fatal and non fatal lactic acidosis with metformin use in type 2 diabetes mellitus
-
Risk of fatal and non fatal lactic acidosis with metformin use in type 2 diabetes mellitus. Salpeter S, Greyber E, Pasternak G, Cochrane Database Syst Rev 2010 4 D0002967
-
(2010)
Cochrane Database Syst Rev
, vol.4
-
-
Salpeter, S.1
Greyber, E.2
Pasternak, G.3
-
5
-
-
14644390253
-
Comparative Outcomes Study of Metformin Intervention versus Conventional Approach: The COSMIC Approach Study
-
DOI 10.2337/diacare.28.3.539
-
Comparative outcomes study of metformin intervention versus conventional approach: the COSMIC Approach study. Cryer DR, Nicholas SP, Henry DH, Mills DJ, Stadel BV, Diabetes Care 2005 28 539 543 10.2337/diacare.28.3.539 15735184 (Pubitemid 40315310)
-
(2005)
Diabetes Care
, vol.28
, Issue.3
, pp. 539-543
-
-
Cryer, D.R.1
Nicholas, S.P.2
Henry, D.H.3
Mills, D.J.4
Stadel, B.V.5
-
6
-
-
0032511566
-
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group
-
9742977
-
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998 352 854 865 9742977
-
(1998)
Lancet
, vol.352
, pp. 854-865
-
-
-
7
-
-
0344420380
-
Risk of Fatal and Nonfatal Lactic Acidosis with Metformin Use in Type 2 Diabetes Mellitus: Systematic Review and Meta-analysis
-
DOI 10.1001/archinte.163.21.2594
-
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: systematic review and meta-analysis. Salpeter SR, Greyber E, Pasternak GA, Salpeter EE, Arch Intern Med 2003 163 21 2594 2602 10.1001/archinte.163.21.2594 14638559 (Pubitemid 37464417)
-
(2003)
Archives of Internal Medicine
, vol.163
, Issue.21
, pp. 2594-2602
-
-
Salpeter, S.R.1
Greyber, E.2
Pasternak, G.A.3
Salpeter, E.E.4
-
8
-
-
0032969589
-
Incidence of lactic acidosis in metformin users
-
DOI 10.2337/diacare.22.6.925
-
Incidence of lactic acidosis in metformin users. Stang M, Wysowski DK, Butler Jones D, Diabetes Care 1999 22 925 10.2337/diacare.22.6.925 10372243 (Pubitemid 29241046)
-
(1999)
Diabetes Care
, vol.22
, Issue.6
, pp. 925-927
-
-
Stang, M.1
Wysowski, D.K.2
Butler-Jones, D.3
-
9
-
-
84859497417
-
Metformin-associated lactic acidosis masquerading as ischemic bowel
-
10.1016/j.amjmed.2011.11.012
-
Metformin-associated lactic acidosis masquerading as ischemic bowel. Correia CS, Bronander KA, Am J Med 2012 125 5 9 10.1016/j.amjmed.2011.11.012
-
(2012)
Am J Med
, vol.125
, Issue.5
, pp. 59
-
-
Correia, C.S.1
Bronander, K.A.2
-
10
-
-
0032917623
-
Lactic acidosis in metformin-treated patients. Prognostic value of arterial lactate levels and plasma metformin concentrations
-
DOI 10.2165/00002018-199920040-00006
-
Lactic acidosis in metformin-treated patients. Prognostic value of arterial lactate levels and plasma metformin concentrations. Lalau JD, Race JM, Drug Saf 1999 20 377 384 10.2165/00002018-199920040-00006 10230584 (Pubitemid 29196913)
-
(1999)
Drug Safety
, vol.20
, Issue.4
, pp. 377-384
-
-
Lalau, J.-D.1
Race, J.-M.2
-
11
-
-
79955785504
-
Metformin associated lactic acidosis: Incidence and clinical correlation with metformin serum concentration measurements
-
10.1111/j.1365-2710.2010.01192.x 21545617
-
Metformin associated lactic acidosis: incidence and clinical correlation with metformin serum concentration measurements. de Laar IR VB-v, Vermeij CG, Doorenbos CJ, J Clin Pharm Ther 2011 36 3 376 382 10.1111/j.1365-2710.2010. 01192.x 21545617
-
(2011)
J Clin Pharm Ther
, vol.36
, Issue.3
, pp. 376-382
-
-
De Laar Ir, V.-V.1
Vermeij, C.G.2
Doorenbos, C.J.3
|